RE: NONMEM 7 Update
Dear All:
Icon Development Solutions has invested in the further
development of NONMEM. By mutual agreement with the University of
California at San Francisco, NONMEM 7 is intellectual property belonging
to IDS. However, IDS will continue to pay royalties to UCSF.
The business plan under which NONMEM 7 was developed calls for
the protection of the I.P. involved. In addition, NONMEM 7 contains
several updated routines developed and owned by IMSL (Visual Numerics
Inc.). Our agreement with IMSL stipulates that we will not distribute
their source code. The installer will compile the software but will not
allow the unencrypted source code to remain on the users computer. The
licensing agreement will also stipulate that any attempt to access the
source code will be a violation of the agreement.
Some source code will be left unencrypted for various reasons,
one being the need for users to change certain values in SIZES and
perhaps other resource routines.
Tom
Thomas M. Ludden Ph.D.
Vice-President, Pharmacometrics R&D
ICON Development Solutions
Tel: + 1 410 696 3040
Mob: + 1 410 258 2411
Fax: + 1 410 480 0776
Email: [email protected]
Web: www.icondevsolutions.com
http://emailsignature/stationary/Icon_Development_Solutions.gif
Quoted reply history
________________________________
From: Eleveld, DJ [mailto:[email protected]]
Sent: Thursday, July 02, 2009 6:11 AM
To: Ludden, Thomas; [email protected]
Subject: RE: [NMusers] NONMEM 7 Update
Can anyone explain what advantages encryted source code might have?
For me at least, the NONMEM source code is already functionally
encrypted because of my poor understanding of Fortran. But it is
unclear to me what problem encryted source code actually solves. Can
anyone enlighten me?
Douglas Eleveld
________________________________
From: [email protected] on behalf of Ludden, Thomas
Sent: Wed 01/07/2009 9:21 PM
To: [email protected]
Subject: [NMusers] NONMEM 7 Update
Dear All:
This is just a brief update regarding the availability of NONMEM 7. We
had hoped to begin distribution of this new version at this time.
However, there are some final code changes to be made followed by
thorough testing. We hope to be able to begin distribution in early
August.
Please be certain that the contact information that we have on file for
your license(s) is up to date. This is the person to whom NONMEM 7 will
be sent . Please send any updates regarding the correct contact person
to [email protected] <mailto:[email protected]> .
Please note that NONMEM 7 will have a licensing system. More details
will be provided as we approach the release date.
Our experience with distributing binary code to the beta testers was
very mixed. Some testers had no problems; others had considerable
difficulty with achieving a successful installation. We are now
considering the distribution of NONMEM 7, for the most part, as
encrypted source code. An installation program will be included. The
SIZES file and several other resource files will be left unencrypted so
that the user can make desired changes prior to compilation as was
possible with previous versions. This change in our method of
distribution will require that a revised licensing agreement be
executed.
Regards,
Bob Bauer
Vice-President, Pharmacometrics
Alison Boeckmann
Consultant
Bill Bachman
Director, Pharmacometrics R&D
Tom Ludden
Vice-President, Pharmacometrics R&D
ICON Development Solutions
Tel: + 1 410 696 3040
Mob: + 1 410 258 2411
Fax: + 1 410 480 0776
Email: [email protected]
Web: www.icondevsolutions.com